Subscribe
patent-istock-579425600-duncan-andison
Duncan_Andison / iStockphoto.com
17 May 2019Americas

Federal Circuit invalidates Nuvo’s Vimovo patents

The US Court of Appeals for the Federal Circuit has delivered a blow to Nuvo Pharmaceuticals by reversing a decision which had upheld the validity of the Canadian company’s pain relief drug Vimovo (naproxen/esomeprazole magnesium).

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Dr Reddy’s found to infringe arthritis drug patent
17 July 2017   A New Jersey judge has ruled today that Dr Reddy’s Laboratories infringed a patent owned by Horizon Pharma.
Americas
Horizon accuses Actavis of infringing Vimovo patents
12 August 2016   Horizon Pharma has filed a complaint against Actavis accusing it of infringing three of patents for the Vimovo (naproxen/esomeprazole magnesium) drug.


Editor's picks

Life sciences leaders recognised at LSPN Awards USA 2025
Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025

Editor's picks

Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025
Americas
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
6 May 2025
Americas
Why US patent reform is ‘essential’ for US economic prosperity and security
29 April 2025
Europe
Meril v Edwards: Harmonisation of obviousness at the UPC and the EPO
24 April 2025
Americas
WIPR Diversity & Inclusion reveals Top 100 People in IP for 2025
24 April 2025
Big Pharma
AstraZeneca unit faces class-action suit over alleged Soliris monopoly
17 April 2025

More on this story

Americas
Dr Reddy’s found to infringe arthritis drug patent
17 July 2017   A New Jersey judge has ruled today that Dr Reddy’s Laboratories infringed a patent owned by Horizon Pharma.
Americas
Horizon accuses Actavis of infringing Vimovo patents
12 August 2016   Horizon Pharma has filed a complaint against Actavis accusing it of infringing three of patents for the Vimovo (naproxen/esomeprazole magnesium) drug.

More on this story

Americas
Dr Reddy’s found to infringe arthritis drug patent
17 July 2017   A New Jersey judge has ruled today that Dr Reddy’s Laboratories infringed a patent owned by Horizon Pharma.
Americas
Horizon accuses Actavis of infringing Vimovo patents
12 August 2016   Horizon Pharma has filed a complaint against Actavis accusing it of infringing three of patents for the Vimovo (naproxen/esomeprazole magnesium) drug.

More features

Life sciences leaders recognised at LSPN Awards USA 2025
UK-India trade deal is ‘a missed opportunity for UK pharma’, says industry body
LSPN: Counsel grapple with AI’s impact on training and critical thinking
'Nothing can stand in the way of our work': Ukraine resumes IP system
LSPN: Trump's policy storm causing chaos and confusion
Taylor Wessing expands in Europe with Paris team
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
ResMed voids sleep apnoea tech patent at PTAB